Form 483

Philip NMI Raskin Form 483, 2018-02-20

FDA issued a Form 483 to Philip NMI Raskin on 2018-02-20 with 1 public-safe observation.

483· Form 483 issuedHuman Drugs1 observation

Philip NMI Raskin · Dallas, United States · Issued February 20, 2018

Overview

  • 1 public-safe observation is available for this inspection.
  • 1 structured CFR citation is represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

20 Feb 2018
21 CFR 312.60

FD-1572, protocol compliance

Cited by Janet B Abt

Inspected site

PNPhilip NMI RaskinDallas, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 312.60Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 1 observation

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere